Kateryna TRYFONOVA

'Healthcare platform Doctolib has conquered France — but can it take on Europe?' Lloyd Price, HealthTech M&A Advisor and Partner at Nelson Advisors shares his thoughts with Daphné Leprince-Ringuet from Sifted discussing Doctolib, their continued success, big future and potential next moves. 'Few startups in France can claim to have changed the way people behave in as systemic a way as Doctolib. Launched in 2013 by Stanislas Niox-Chateau, Doctolib has become a key component of the country’s healthcare system. Its first product — an online booking platform that lets patients schedule doctor appointments — saw huge adoption in a sector with very little digitisation. > Today, the company covers “almost all of the French population”, says Doctolib’s CFO Pierre Vergnes. It counts 80m patient accounts spanning three countries, of which the vast majority remains in France. Doctolib also has 19m users in Germany, which it expanded to in 2016, and a “nascent” number of users in Italy, launched in 2021. > During the Covid pandemic, the French government selected the company as an official partner to manage vaccination appointments. “[In France], they’re a utility company for running healthcare infrastructure now,” says Lloyd Price, a healthtech M&A advisor. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected] > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i https://lnkd.in/edDCqmrz

1

1 commentaire

Looking forward to sharing my perspectives and hearing how others are approaching the global VC landscape at this session at #GRIC2024!

19

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

7

1 commentaire

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Predicting the exact market conditions for HealthTech IPOs in 2025 is challenging, as it depends on numerous factors. However, based on current trends and historical data, we can make some educated assumptions. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

2

1 commentaire

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

4

1 commentaire

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

3

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. #HealthTech #IPO #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy

5

1 commentaire

🔍 France's Medtech sector is at a pivotal moment...In 2023, financial sponsor exits in French healthcare totaled just €141M compared to €1.3B in Germany and €8.1B in the US! Despite its rich history in medical innovation, the lack of local private equity investment is holding back promising companies. France currently accounts for 14% of the European medical device market but lags behind Germany’s 27%. The good news? There’s a backlog of mature French medtech firms generating revenues of €20M to €30M that are ready to scale up, but they need more local growth capital. Upcoming deals, such as Astorg’s stake in Echosens and Theravia’s exit pipeline, highlight the potential waiting to be unlocked. With the new European Commission expected to simplify regulations, the question remains: how can we harness PE support to ensure France's medtech sector thrives? Source : ION Analytics, Med Tech Europe #Healthcare #Medtech #Privateequity #Investments #France ——— I am Alexis - French pharmacist turned entrepreneur. My company BTHT is connecting senior industry experts, ex-payors, and KOLs with consultants and investors in Life Sciences and Healthcare for expert calls and senior advisory. Join 16K+ followers by clicking my name + follow 🔔 Join 1.4K+ subs to my weekly newsletter 💌

19

🌍 𝑴𝒆𝒆𝒕 𝒕𝒉𝒆 𝒎𝒐𝒔𝒕 𝒂𝒄𝒕𝒊𝒗𝒆 𝑯𝒆𝒂𝒍𝒕𝒉𝑻𝒆𝒄𝒉 𝒂𝒏𝒅 𝑩𝒊𝒐𝒕𝒆𝒄𝒉 𝒊𝒏𝒗𝒆𝒔𝒕𝒐𝒓𝒔 𝒐𝒇 2024 𝒈𝒍𝒐𝒃𝒂𝒍𝒍𝒚! 🌍 If you’re a startup in the #HealthTech or #Biotech industry, here are some of the top investors around the world actively funding innovative companies: 𝐄𝐮𝐫𝐨𝐩𝐞 • 𝐇𝐢𝐠𝐡𝐓𝐞𝐜𝐡 𝐆𝐫𝐮̈𝐧𝐝𝐞𝐫𝐟𝐨𝐧𝐝𝐬 (Germany): €100K - €3M, Seed Stage • Kurma Partners (France): €500K - €3M, Early Stage • Idinvest Capital Partners (France): €500K - €2M, Seed and Growth Stage • 𝐁𝐎𝐌 𝐁𝐫𝐚𝐛𝐚𝐧𝐭 𝐕𝐞𝐧𝐭𝐮𝐫𝐞𝐬 (Netherlands): €100K - €5M, Pre-seed to Early Stage • Verve Ventures (Switzerland): €500K - €3M, Seed to Series B 𝐀𝐬𝐢𝐚 • Shenzhen Capital Group Co., Ltd (China): $500K - $10M, Seed to Late Stage • Kalaari Capital (India): $500K - $5M, Seed and Early Stage • Chiratae Ventures (India): $100K - $10M, Pre-seed to Series A • @IDG Ventures (India): $500K - $5M, Seed to Early Stage • Antler (Singapore): $100K - $30M, Pre-seed to Series A 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 • Bessemer Venture Partners (USA): $100K - $1B, Seed to Growth Stage • General Catalyst (USA): $100K - $1B, Seed to Series C • 8VC (USA): $500K - $10M, Seed to Series C • Atlas Venture (USA): $100K - $5M, Seed and Early Stage • Lux Capital (USA): $100K - $25M, Seed and Early Stage 𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 • Walden Catalyst Ventures (Israel): $1M - $25M, Seed and Early Stage • Shorooq Partners (UAE): $500K - $5M, Seed and Series A • Crescent Enterprises Ventures (UAE): $500K - $10M, Seed to Growth Stage • Wamda Capital Capital (UAE): $100K - $5M, Seed to Series A • Middle East Venture Partners (MEVP) East Venture Partners (Lebanon/UAE): $100K - $3M, Seed and Early Stage Do you know people which may need this info? Share with them this post. 💼 Are you ready to secure your funding? Let Tech Add-Venture Accelerator help you scale and grow! 🏆 Early Applications are open until October 31! Link in the first comment! Fallow Andreea Marinescu for more insights about how you can secure your next round from investors! #HealthTech #Biotech #Startups #VentureCapital #TechAddventureAccelerator

3

1 commentaire

"What's new in healthcare innovation globally?" I had the pleasure to share my thoughts on this topic at the annual event in Paris hosted by La Poste Santé & Autonomie, which brought together the entire French #healthcare and #healthTech ecosystem. Thank you florence dupre and Olivier Barets for the invitation, and appreciation to my fellow panelists: . François BRAUN: Former Minister of Social Affairs and Health of #France . stephane pierrefitte: Deputy General Director at the University Hospital Group (Psychiatry & Neurosciences) . Hélène GUIMIOT: Head of the Health Service in the Legal Support Department of the French data protection authority (CNIL) . Kathy Malas: Director of Research, Innovation, and Learning at CISSS Montérégie-Ouest, Quebec. Special thanks to Dominique Pon, CEO of La Poste Santé & Autonomie for the great moderation (and great event). The key points of my presentations in a nutshell: The NHS, a cornerstone of British pride, is in crisis according to Lord Darzi's 2024 report (published in Sep 24) Key findings show 33% of Britons now wait over a week for GP appointments, compared to 16% in 2021. Bupa has responded by offering a subscription model for primary care: £17/month for same-day teleconsultations or £22/month for in-person visits, raising concerns about a potential two-tier system. Following the publication of the report, UK Prime Minister Sir Keir Starmer aims to transition the NHS to a digital system. There are already promising initiatives within the NHS like the 42 Integrated Care Systems (ICS) and the GP Practice Improvement Program, which has replaced 30% of face-to-face visits with text consultations. AI could also play a crucial role, with most NHS staff supporting its use in patient care (76%) and administration (81%). Four key #AI archetypes include: 1️⃣ Non-clinical AI for consumers/patients AI-based care navigation, seen with US companies like Transcarent or UnitedHealth Group's Find Care & Costs tool. 2️⃣ Clinical AI for consumers/patients AI predictive models intercepting disease through blood analysis (e.g., Function Health, Aware) or imaging (e.g., Neko Health). 3️⃣ Clinical AI for health professionals AI Clinical Decision Support (AI-CDS), especially in radiology (75% of FDA approved AI-CDS), but also beyond with companies like Tempus AI in AI-oncology. 4️⃣ Non-clinical AI for healthcare professionals AI-enhanced administrative management (like Ambient AI, ...), likely to see the fastest adoption in the short term. Three potential winners in the AI healthcare transformation: Epic: Aiming to orchestrate AI in hospitals with its App Store Showroom. Mayo Clinic: Already using 70+ AI algorithms and developing the Mayo Clinic Platform_Connect, a data hub connecting major hospitals for AI model training. La Poste Santé & Autonomie: An innovative public player acting as a trusted intermediary between healthcare systems, industry, and regulators to implement new models of care.

147

7 commentaires

💪 We are very proud to have been included among the #key #startups in #digital #health who are helping to #combat #medical #deserts. Since CONCILIO's creation, we have been helping companies find solutions to support their employees' health in France and in more than 64 other countries. Our #unique #medical #concierge service offers : ✅ #Teleconsultation, 24/7, in five languages. ✅ #Digital #health #checkups focused on general health, women's health, mental health, and more. ✅ Daily support by #recommending #top #specialists endorsed by their peers to prevent medical wandering. ✅ #Medical #appointment #booking with general practitioners and specialists to save time and reduce the mental load for employees and their families, particularly those living in medical deserts. #digitalhealth #telemedecine #telehealth #bestdigitalhealthcompany #concilio #medicalconcierge

3

3 commentaires

how brillant! At #OrphanHealthcare, we've just kicked open the doors to an new opportunity that's as big as the free pizza at a startup launch! We’re getting a new office at the end of summer and offering a great, still free 120 sqm of ultra-modern office space for your, absolutely amazing! And trust me, this isn't your average, everyday office space at the edge of Zurich. It combines work and work-life balance. 😍 Here’s the Scoop on the Space: 🖐🏻 If size Matters: A whopping 350 sqm of chic, open-plan office space begging you to throw some desks and dreams into it. And 120 sqm are still available for you. 🛀🏻 Design & Comfort: It’s got everything – 2 snazzy meeting rooms for when you need to impress, a lounge for lounging (obviously), an open kitchen to test your cooking show fantasies, and even an event spot for your TEDx rehearsal. 🤓 Tech Ready: All the state-of-the-art fixings to make sure you can tweet faster, work smarter, and Netflix chill harder. ⛳ Location, Location, Location: Right on the nerve center of everything cool - next to trams, trains, and an expressway to pretty much everywhere. 🚀 Why You’ll Love It: Price Tag. It’s about amazing for the prices others pay in downtown Zurich. Flex Appeal. Mold it, shape it, and dance in it – make this space your own! Network Nirvana. Join a community of thinkers, leaders, and occasional coffee-sharing who are all on the path to greatness. 👥 Limited Edition! This isn’t a drill people, spaces like this don’t come by often and they don’t stay free for long. It’s time to level up your workplace vibe and get your team into something stellar. And 2 wonderful partners are on board: Q4BS GmbH and The Social Mall - Center for Social Quality Impact 📞 Ready to claim your space in our new corporate paradise? Hit us up at [email protected] and let’s chat about making magic happen in our new office! #Sustainable #Campus! 🎈 #OfficeSpace #Workspace #ModernOffice #BusinessOpportunity #OfficeForRent #ProfessionalSpace #CollaborationSpace

3

2 commentaires

🧬 Latest Deals in Healthcare & Life Sciences 💼 💼 Extens has acquired a majority stake in Medicore, marking its first investment outside France, as part of its European expansion strategy, focusing on enhancing mental health solutions and EHRs for over 25,000 healthcare professionals. 💰 Kurma Partners has successfully closed €140m in its first closing of Biofund IV, aiming to raise a total of €250m by 2025 for innovative therapeutics investments. 💰 Healius has entered into a binding agreement to sell its Lumus Imaging subsidiary to Affinity Equity Partners for an enterprise value of A$965m (US$669m), enabling Healius to focus on its pathology strategy and enhance customer service and digital technologies. 🤝 Fondo Italiano d'Investimento SGR has invested €10m to acquire a minority stake in Intrauma, a developer of advanced orthopaedic medical devices, to support its growth targets and product expansion. 🇬🇧 Huma has acquired eConsult and launched Huma Workspace, aiming to create a comprehensive digital-first healthcare platform for the NHS. 💰 Asabys Partners has successfully closed its Sabadell Asabys Health Innovation Investments II Fund at €180m, surpassing its target of €150m, to invest in biopharma, medical devices, and digital health companies. 🔬 Bruker Corporation has acquired Dynamic Biosensors, enhancing its biophysical portfolio for biomolecular interaction analysis. 💼 Miura Partners has closed its fourth flagship fund, Miura Fund IV, at its hard cap of €475m, marking a total fundraising of €800m in 2024, with significant investments in family-owned businesses across healthcare, education, and other sectors 🩺 Mölnlycke Health Care has finalized its acquisition of PGF Industry Solutions, the Austrian manufacturer of Granudacyn wound cleansing and moistening solutions. Source : Investors in Healthcare ——— I am Alexis - French pharmacist turned entrepreneur. My company BTHT connects experts with consultants and investors in Life Sciences and Healthcare for expert calls and senior advisory. For more content like this 👇 Join 15K+ followers by clicking my name + follow 🔔 Join 1.4K+ subscribers to my weekly newsletter 💌

25

2 commentaires

🌍 Exciting times ahead for digital health in France! I had the honor of speaking at the roundtable on "Digital Medical Devices: Where do we stand in their assessment and what healthtech stakeholders need to know?" organized by the Agence de l'innovation en santé (Lise ALTER, Camille Schurtz 👏 ) at the "Next generation of clinical research" event in Lille. The discussion was rich with insights on the current landscape of research and the future of digital therapeutics in France, especially. Special thanks to our moderator, Line FARAH (Ministère de la Santé), and my fellow speakers: Jérôme Fabiano (EIT Health France), Corinne Collignon (Haute Autorité de Santé), Sarah Zohar (INSERM), Dr. Joris Giai (CHU Grenoble Alpes) and Louisa Stüwe (Ministère de la Santé). 💡 One of the key insights: YES, foreign clinical data can be used to apply for reimbursed of a digital medical device in France! Let's connect and explore opportunities together! 🚀

95

1 commentaire

Curious about the intersection of health innovation and venture capital? Don’t miss this episode featuring Anne-Sophie Saint-Martin, Partner at Newfund, as she shares her journey and insights on investing in health startups and launching a fund dedicated to brain startups. In this podcast, you’ll discover: ✅ Anne-Sophie’s unique background and what drives her passion for health investments. ✅ Why health tech is a unique and complex investment field, often overlooked for this very reason, yet incredibly compelling both for its societal impact and its financial performance potential. ✅ How this focus perfectly aligns with Newfund’s mission of bridging Europe and the U.S. since its launch in 2008. Newfund continues to champion bold ideas and international synergies across markets. Tune in to learn how we’re shaping the future of health and innovation on both sides of the Atlantic! 🌎✨ 🎧 Listen now: https://lnkd.in/ei_2ZY2E Thx Benjamin WATTINNE for this great podcast series! #VentureCapital #HealthTech #BrainHealth #Innovation #Startups #Europe #USA #HekaFund

33

2 commentaires

At Beo Healthcare, we partner with multiple health professionals to ensure that #alix, our hybrid artificial intelligence, includes the right features and benefit for patients' quality of life. Alix is designed to target multiple diseases, including #cancer We want to thank MD, brain surgeons at CHU de Brest for sharing relevant research publications with us to allow the right developments of Alix, in particular to have a solution that is customized, specific to each individual Extracts from the Abstract ⤵️: " Fatigue is one of the most common adverse effects of cancer that might persist for years after treatment completion in otherwise healthy survivors. Cancer-related fatigue causes disruption in all aspects of quality of life and might be a risk factor of reduced survival. The prevalence and course of fatigue in patients with cancer have been well characterized and there is growing understanding of the underlying biological mechanisms. Inflammation seems to have a key role in fatigue before, during, and after cancer-treatment. However, there is a considerable variability in the presentation of cancer-related fatigue, much of which is not explained by disease-related or treatment-related characteristics" "... a variety of intervention approaches have shown beneficial effects in randomized controlled trials, including physical activity, psychosocial, mind–body, and pharmacological treatments..." #md #hospital #cancer #AI #AIforHealth #Healthcare #Europe #USA #futureofmedicine #physicalactivity #customizedmedecine #patientqualityoflife #brainsurgeon #fatigue #cancerrelatedfatigue Sophie Deniel Yannick GUILLODO Chloé Le Douarin Sullivan Gauville Lucas Morisseau Maxime B'chir Benoît Quero Jean-Luc DUFOUR Mathieu Champenois Yann Le DOUARIN Nature Research Custom Media UCLA MACMILLAN PUBLISHERS INTERNATIONAL LIMITED

8

📍 [Tibi Deep Tech Roundtable] On October 15th, the Tibi Deep Tech Workshops on Digital Health and New Space gathered key experts to explore the future of innovation in these fields. Newfund was represented by Pierre Frouin, Operating Partner, who shared valuable insights into the competitive landscape of Healthcare, a strategic sector for the VC fund for more than 10 years. 🇺🇸🧠 Pierre discussed the Go-to-Market strategies for startups, highlighting the importance of balancing U.S. expansion with European growth. He explained how this approach, especially through Heka, helps accelerate progress in the BrainTech and HealthTech sectors. The roundtable also demonstrated how digital healthcare unites a wide range of players—corporations like Pfizer (Luca Mollo) and Dassault Systèmes, public institutions like Agence de l'innovation en santé and Inserm, startups like Volta Medical, and VCs such as Jefferies, Ventech, and Sofinnova Partners—all working together to foster the rise of international leaders, following Philippe Tibi’s initiative. cc Pierre Frouin, Anne-Sophie Saint-Martin, François Veron, Constant Beroulle, Carla Paillardon #Newfund #RoadToTheUSA #Heka #BrainTech #Tibi

55

2 commentaires

Last week, I had the pleasure of sharing notes on go-to-market strategies for MedTech and digital health startups with Romy Benninga, MSc, BCMAS Co-founder of Digital Health Works — while sipping a warm matcha latte in a Lisbon cafe. 🍇 One key insight stood out: the undeniable power of a sound low-hanging fruit strategy. It’s about prioritising accessible opportunities that deliver quick, impactful results, laying a solid foundation for long-term growth. Why is this important? Early wins help build traction and credibility, validate your product, and generate revenue, which is critical in the capital-intensive world of MedTech. One standout example is biotech company CureVac. They initially focused their mRNA technology on a specific, high-impact application: developing a vaccine for rabies. This strategic choice allowed them to target a well-defined market with a clear, urgent need, while also showcasing the broader potential of their platform. By starting with this niche, CureVac was able to gather critical data, build credibility within the scientific and regulatory communities, and pave the way for expansion into larger markets, including COVID-19 and promising cancer therapeutics currently in development. This approach highlights the importance of: 🎯 Identifying niche markets or early adopters who stand to benefit most from your solution, particularly in areas with fewer regulatory hurdles. 🔑 Building momentum quickly with a product-market fit that’s easy to execute. 🚀 Leveraging early success to scale and capture larger, more complex markets. For MedTech startups, focusing on these "low-hanging fruits" can be the difference between getting lost in a long regulatory and sales cycle and achieving early, meaningful traction. What strategies have you seen work in the MedTech space? 🌍 #MedTech #GoToMarket #StartupSuccess #Innovation #HealthTech #Entrepreneurship

14

2 commentaires

Good Morning, folks ! Great news to start the week—the VC machine is slowly waking up and fueling European HealthTech startups !👇 In the first half of 2024, investor interest in European startups surged, with €27.8bn invested, a 16% rise from H1 2023 (Sifted data). Notably, public institutions are key players, with the European Innovation Council and Bpifrance actively supporting startups. Bpifrance, in particular, was involved in nearly 17% of all French deals in H1. Here are the top 15 leading investors in European startups this year, according to Anne Sraders and Sifted 👇 1- Antler : 82 deals 2- SFC Capital : 78 deals 3- Bpifrance : 63 deals 4- European Innovation Council and SMEs Executive Agency (EISMEA) : 44 deals 5- Y Combinator : 36 deals 6- HTGF | High-Tech Gründerfonds : 35 deals 7- Kima Ventures : 23 deals 8- Octopus Ventures : 23 deals 9- EIT - European Institute of Innovation and Technology : 22 deals 10- BNP Paribas : 19 deals 11- CDP Venture Capital SGR : 18 deals 12- Speedinvest : 17 deals 13- CDTI Innovación - Centro para el Desarrollo Tecnológico y la Innovación : 17 deals 14- Scottish Enterprise : 17 deals 15- Earlybird Venture Capital : 17 deals Link to the article in the comment 👇

13

4 commentaires